About
Small Molecules, Biologics, Protein Technologies
Areas of Focus
Categories
Non-PharmaceuticalSmall Molecule Pharmaceutical
Clinical Trials (10)
View allTotal Trials
10
As Lead Sponsor
10
As Collaborator
0
Total Enrollment
321
By Phase
PHASE1: 4PHASE2/PHASE3: 1PHASE2: 5
By Status
TERMINATED: 5COMPLETED: 5
Clinical Trials Pipeline10 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Today
Hover over trial bars to see details
Recent Trials
NCT05349435Lead Sponsor
A Healthy Volunteer Study to Compare Fezagepras (PBI-4050) With Sodium Phenylbutyrate
PHASE1Terminated
8 participants
Started: May 13, 2022 · Completed: Jun 30, 2022
NCT04695041Lead Sponsor
A Healthy Volunteer Study of PBI-4050
PHASE1Completed
65 participants
Started: Dec 9, 2020 · Completed: Oct 5, 2021
NCT04068259Lead Sponsor
Single Ascending Dose Study of PBI-4547 in Healthy Subjects
PHASE1Terminated
24 participants
Started: Sep 5, 2019 · Completed: Oct 8, 2019
NCT03637049Lead Sponsor
Effect of PBI-4050 on the Pharmacokinetics of Midazolam in Heathy Adult Subjects
PHASE1Completed
22 participants
Started: Jul 17, 2018 · Completed: Aug 22, 2018
NCT03184584Lead Sponsor
Open-Label Rollover Study of PBI 4050 in Subjects With Alström Syndrome
PHASE2/PHASE3Terminated
10 participants
Started: Oct 9, 2017 · Completed: May 8, 2020
Locations (1)
Headquarters
Laval, QC, Canada
Map
Loading map...